Invention Grant
US08257697B2 Use of platelet activating factor acetylhydrolase as biomarker for anaphylaxis
有权
使用血小板激活因子乙酰水解酶作为过敏反应的生物标志物
- Patent Title: Use of platelet activating factor acetylhydrolase as biomarker for anaphylaxis
- Patent Title (中): 使用血小板激活因子乙酰水解酶作为过敏反应的生物标志物
-
Application No.: US12262949Application Date: 2008-10-31
-
Publication No.: US08257697B2Publication Date: 2012-09-04
- Inventor: Peter Vadas
- Applicant: Peter Vadas
- Applicant Address: CA Toronto
- Assignee: Allertech Laboratory Inc.
- Current Assignee: Allertech Laboratory Inc.
- Current Assignee Address: CA Toronto
- Agency: Blake, Cassels & Graydon LLP
- Agent Santosh K Chari
- Main IPC: A61K38/46
- IPC: A61K38/46 ; C12Q1/34

Abstract:
A method for determining a patient's susceptibility to anaphylaxis comprises assaying the activity of platelet activating factor acetylhydrolase (PAF-AH) activity and comparing the measured activity to a reference value, wherein the level of PAF-AH activity inversely correlates with the susceptibility to anaphylaxis. The method further comprises determining the severity of anaphylaxis by correlating the degree of reduced PAF-AH activity to the reference value. The method further comprises measuring IgE concentration and comparing the measured concentration to a reference concentration. The invention further provides a method for diagnosing anaphylaxis in a patient comprising measuring the serum concentration of platelet activating factor (PAF) and comparing the measured concentration to a reference value, wherein the concentration of PAF correlates directly with severity of anaphylaxis. The invention also provides a kit for performing the required assay or assays.
Public/Granted literature
- US20090110675A1 USE OF PLATELET ACTIVATING FACTOR ACETYLHYDROLASE AS BIOMARKER FOR ANAPHYLAXIS Public/Granted day:2009-04-30
Information query
IPC分类: